Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab improved hair and skin in a woman with Netherton syndrome.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Dupilumab may help treat alopecia areata without needing high IgE levels.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Using 2.5 mg/mL triamcinolone acetonide is effective for hair growth in alopecia areata with fewer side effects.

Some drugs used to treat inflammation may cause hair loss.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Trichotillomania was successfully treated with risperidone and naltrexone.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Adalimumab improved folliculitis decalvans in most patients.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Triamcinolone acetonide injections help hair regrow quickly in mild alopecia but not in severe cases.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Tofacitinib is effective and safe for treating alopecia areata.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.